Variant report

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr20:31658314..31660375-chr20:31662035..31664440,2	K562	blood:
2	chr20:31658875..31660916-chr20:31662877..31664701,3	K562	blood:

rSNPs within LD-proxies of this variant (count:34)

rs_ID	r²[population]
rs13044428	0.84[AMR][1000 genomes];0.95[ASN][1000 genomes]
rs1972199	0.84[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs2070321	0.89[ASN][1000 genomes]
rs2070322	0.82[ASN][1000 genomes]
rs2070324	0.82[ASN][1000 genomes]
rs2070325	0.82[ASN][1000 genomes]
rs2073325	0.85[AMR][1000 genomes];0.95[ASN][1000 genomes]
rs2093067	0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs2424942	0.84[AMR][1000 genomes];0.95[ASN][1000 genomes]
rs2424945	0.92[ASN][1000 genomes]
rs2424946	0.81[AMR][1000 genomes];0.92[ASN][1000 genomes]
rs2424947	0.81[AMR][1000 genomes];0.92[ASN][1000 genomes]
rs2889732	0.82[ASN][1000 genomes]
rs372054	0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs398444	0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs4911290	0.84[ASN][1000 genomes]
rs4911291	0.85[ASN][1000 genomes]
rs4911292	0.85[ASN][1000 genomes]
rs4911293	0.85[ASN][1000 genomes]
rs4911295	0.90[ASN][1000 genomes]
rs4911296	0.90[ASN][1000 genomes]
rs4911297	0.90[ASN][1000 genomes]
rs6057715	0.85[ASN][1000 genomes]
rs6057717	0.90[ASN][1000 genomes]
rs6059069	0.90[ASN][1000 genomes]
rs6087441	0.88[ASN][1000 genomes]
rs6088084	0.82[ASN][1000 genomes]
rs6088085	0.85[ASN][1000 genomes]
rs6088091	0.90[ASN][1000 genomes]
rs6141876	0.93[ASN][1000 genomes]
rs6141877	0.88[ASN][1000 genomes]
rs7273967	0.82[ASN][1000 genomes]
rs761935	0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs761936	0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.90[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1056411	chr20:31057037-31942835	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	62 gene(s)	inside rSNPs	diseases
2	esv2758519	chr20:31495807-31748166	Enhancers Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
3	esv2758792	chr20:31495807-31748166	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:4 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:31655000-31659800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr20:31655200-31660000	Enhancers	Primary hematopoietic stem cells short term culture	blood
3	chr20:31655200-31660000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr20:31657400-31670600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

Quick Search: